Status:
WITHDRAWN
Study of Peripheral Tissue Oxygenation in End-stage Liver Disease Patients During Liver Transplantation
Lead Sponsor:
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Conditions:
End Stage Liver Disease
Eligibility:
All Genders
18+ years
Brief Summary
End - stage liver disease can cause many problems to the patients including fatigue, weakness,jaundice, confusion, abdominal pain and distension. Another important problem is the cardiovascular system...
Detailed Description
End - stage liver disease patients scheduled for liver transplantation will be enrolled. They will receive normal standard of care. The VOT assessment using a non-invasive, integrated research device ...
Eligibility Criteria
Inclusion
- Adult patients suffering from end-stage liver disease scheduled for liver transplantation.
Exclusion
- Patients with known peripheral vascular disease
- Patients receiving Oxygen therapy
Key Trial Info
Start Date :
February 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2016
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01794637
Start Date
February 1 2013
End Date
March 1 2016
Last Update
October 4 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital, London Health Science Center
London, Ontario, Canada, N6A 5A5